Importance & Scope:

      Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and vaccinology as they relate to immunization.

Why San Francisco? 

San Francisco, More than 50,000 people die in the U.S each year from diseases that could have been prevented with a simple vaccine. Influenza is by far the biggest killer, but there are also regular outbreaks of measles, meningitis, and pertussis. Ebola virus and Pertussis (or whooping cough) is currently epidemic in California. Unvaccinated people can spread disease to other adults and the children too young to be immunized. These are the some of the Global market research analysis for Vaccines approved by BCC. Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017, for DNA vaccines was valued at $305.3 million in 2014, and further to $2.7 billion by 2019, influenza market will grow from nearly $6 billion in 2018.  The protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, for Multiple Sclerosis (MS) disease-modifying products is expected to grow to nearly $14.2 billion in 2018. The global protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.

Figure 1: WHO Statastics of Global Vaccines Market Size[1]

Conference Highlights: 

· Vaccines and the basic immune system

· Cellular and molecular-based vaccines

· Vaccines against infectious diseases

· Therapeutic vaccine manufacturing, production and development

· Logical and ethical issues and vaccines

· New approaches for B and T cells

· Experimental and clinical evaluation of therapeutic vaccines

· Basic Vaccinology and modern vaccine discovery technologies

· Innate and Adaptive Immune Responses to Vaccination

· Vaccinations Focusing on Induction of B or T cell Responses

· Novel Approaches in Design of Cellular and Molecular-Based Vaccines

· Vaccines Against Infectious Diseases and Cancers

· Manufacturing, Production, and Development of Vaccines

· Regulatory and Ethical Issues of Vaccines and Public Acceptance

· Translational, Clinical Evaluation and Field Trials of Vaccines

· Modern Technologies in Vaccine Discovery and Development

· Age-specific Immune Response to Vaccination

· Cancer Vaccines

· HIV/AIDS, STD

· Ebola Vaccines

· Diabetes Vaccines

Why to attend???

Vaccines -2015 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://vaccines.global-summit.com/america/sponsors.php

Major Vaccines Associations in & around San Francisco

· Bivariate Association

· Dogwalkers Association

· American veterinary Medical Association

· Association of veterinary vaccination

Major Vaccines Associations Globally

· The International Society for Interferon and Cytokine Research

· The International Society of Neuroimmunology

· The International Union of Immunological Societies

· The Society for Mucosal Immunology

· The Society for Leukocyte Biology

· Transplantation Society

· British Society for Immunology

· Cell Death Society

· European Federation of Immunological Societies

· European Society of Gene Therapy

· Federation of African Immunological Societies

· Federation of American Societies for Experimental Biology

· Federation of Clinical Immunology Societies

· Immune Deficiency Foundation

· Infectious Diseases Society of America

Target Audience:

Vaccines 2015 Targets, CEO’s , Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally

Vaccines sales in global leader companies 2012(1^st quarter):

· Pfizer 2.2 B $

· Sanofi  1.7 B $

·  Merck & Co 1.8 B $

· GSK 2.5 B $

· Novartis 0.44 B $

· EBS 0.88 B $

Figure 4: Global Vaccines sales[2]

Immunology Associated Universities

In and Nearby Universities

· University of San Francisco 

· University of California San Francisco

Top Global Immunology Universities

   Rank                        University Name

1 Harvard University

2 University of California--San Francisco

3 Stanford University

3 Yale University

5 Johns Hopkins University

5 Washington University in St. Louis

7 Duke University

7 University of Pennsylvania

9 University of Texas Southwestern Medical Center--DallasUniversity of California San Franciso

Companies Associated with Vaccines

· CareDx

· Atara

· Biotherapeutics

· Benitec Limited  

· InterMune

· Biotron Limited

· BioDiem

· Antisense Therapeutics Limited           

· GlaxoSmithKline Australia Pty Ltd

· Bionomics

· Australian Pharmaceutical Industries (API)   

· BioPharmica Limited

Market Analysis of Vaccines

The Global market research analysis for Vaccines approved by BCC. Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017, for DNA vaccines was valued at $305.3 million in 2014, and further to $2.7 billion by 2019, influenza market will grow from nearly $6 billion in 2018.  The protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, for Multiple Sclerosis (MS) disease-modifying products is expected to grow to nearly $14.2 billion in 2018. The global protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.

Figure 8: Vaccines Market – WHO[3]

Overall Statistics

                                      Figure 9: Top product sales in 2010[4]

References:

^{1. http://who.int/influenza_vaccines_plan/resources/session_10_kaddar.pdf}

^{2. http://www.fiercevaccines.com/special-reports/top-5-vaccine-companies-revenue-2012}

3.^{http://vaccines.global-summit.com/america/index.php}

^{4. http://www.university-list.net/us/rank/univ-1039.htm}